Andrographolide: A review of its anti-inflammatory activity via inhibition of nf-kappab activation from computational chemistry aspects

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 569-576

  Levita, Jutti ^a,b   Nawawi, Asari ^b   Mutalib, Abdul ^c   Ibrahim, Slamet ^b  

^a PADJADJARAN UNIVERSITY   (Indonesia)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^c NATIONAL NUCLEAR ENERGY AGENCY   (Indonesia)

Author keywords

Andrographis paniculata; Andrographolide; Molecular modeling; NF kappaB

Indexed keywords

ANDROGRAPHOLIDE; CYCLOOXYGENASE 2; DITERPENOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEOANDROGRAPHOLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANDROGRAPHIS PANICULATA; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; DRUG ACTIVITY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIVER PROTECTION; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR RECOGNITION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; X RAY CRYSTALLOGRAPHY;

EID: 77955698193     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.569.576     Document Type: Review

References (50)

1. Abu-Ghefreh, A.A., H. Canatan and C.I. Ezeamuzie, 2009. In vitro and in vivo anti-inflammatory effects of andrographolide. Int. Immunopharmacol., 9: 313-318.
2. Akowuah, G.A., I. Zharik and A. Mariam, 2008. Analysis of urinary andrographolides and antioxidant status after oral administration of Andrographis paniculata leaf extract in rats. Food Chem. Toxicol., 46: 3616-3620
3. Amroyan, E., E. Gabrielian, A. Panossian, G. Wikman and H. Wagner, 1999. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine, 6: 27-31.
4. Bao, Z., S. Guan, C. Cheng, S. Wu and S.H. Wong et al, 2009. A novel antiinflammatory role for
5. andrographolide in asthma via inhibition of the nuclear factor-kB pathway. Am. J. Respir. Crit. Care Med., 179: 657-665.
6. Behrens, M., A. Brockhoff, C. Batram, C. Kuhn, G. Appendino and W. Meyerhof, 2009. The human bitter taste receptor hTAS2R50 is activated by the two natural bitter terpenoids andrographolide and amarogentin. J. Agric. FoodChem., 57: 9860-9866.
7. Berkowitz, B., D.B. Huang, F.E. Chen-Park, P.B. Sigler and G. Ghosh, 2002. The X-ray crystal structure of the NF-_B p50_p65 heterodimer bound to the interferon beta-kappa B site. J. Biol. Chem., 277: 24694-24700.
8. Calabrese, C, S.H. Berman, J.G. Babish, X. Ma and L. Shinto et al, 2000. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytotherapy Res., 14: 333-338.
9. Carretta, M.D., P. Alarcon, E. Jara, L. Solis and J.L. Hancke et al, 2009. Andrographolide reduces IL-2 production in T-cells by interfering withNFAT and MAPK activation. Eur. J. Pharmacol.,602: 413-421.
10. Chandrasekaran, C.V., A. Guptaa and A. Agarwal, 2010. Effect of an extract of Andrographis paniculata leaves on inflammatory and allergic mediators in vitro. J. Etnopharmacol., 129: 203-207.
11. Chao, W.W., Y.H. Kuo and B.F. Lin, 2010. Anti-inflammatory activity of new compounds from Andrographis paniculata by NF-kappaB trans activation inhibition. J. Agric. Food Chem.,58: 2505-2512.
12. Chen, J.X., H.J. Xue, W.C. Ye, B.H. Fang and Y.H. Liux et-al, 2009. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol. Pharm. Bull, 32: 1385-1391.
13. Chiou, W.F., C.F. Chen and J.J. Lin, 2000. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br. J. Pharmacol, 129: 1553-1560.
14. Cho, M.L., Y.M. Moon, Y.J. Heo, Y.J. Woo and J.H. Ju et al, 2009. NF-kappa B inhibition leads to increased synthesis and secretion of MTF in human CD4+ T cells. Immunol. Lett, 123: 21-30.
15. Daisy, P., R. Sasikala and A. Ambika, 2009. Analysis of binding properties of phosphoinositide 3-kinase through in silico molecular docking. J. Proteomics Bioinform., 2: 274-284.
16. Fujita, T., R. Fujitani, Y. Takeda, Y. Takaishi, T. Yamada, M. Kido and I. Miura, 1984. On the diterpenoids of Andrographis paniculata: X-ray crystallographic analysis of andrographolide and structuredetermination of new minor diterpenoids. Chem. Pham. Bull., 32: 2117-2125.
17. Handa, S.S. and A. Sharma, 1990a. Hepatoprotective activity of andrographolide against galactosamine and paracetamol intoxication in rats. Ind. J. Med. Res., 92: 284-292.
18. Handa, S.S. and A. Sharma, 1990b. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbon tetrachloride. Ind. J. Med. Res., 92: 276-283.
19. Hidalgo, M.A., A. Romero, J. Figueroa, P. Cortes, I.I. Concha, J.L. Hancke and R.A. Burgos, 2005. Andrographolide interferes with binding of nuclearfactor-kB to DNA in HL-60-derived neutrophilic cells. Br. J. Pharmacol, 144: 680-685.
20. Iruretagoyena, M.I., J.A. Tobar, P.A. Gonzalez, S.E. Sepulveda and C.A. Figueroa et al, 2005. Andrographolide interferes with T-Cell activation andreduces experimental autoimmune encephalomyelitis in the mouse. J. Pharmacol. Exp. Therapeutics,312: 366-372.
21. Ischiropoulos, H., L. Zhu and J.S. Beckman, 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys., 298: 446-451.
22. Koul, LB. and A. Kapil, 1994. Effect of diterpenes from Andrographis paniculata on antioxidant defense system and lipid peroxidation. Ind. J. Pharmacol, 26: 296-300.
23. Kumoro, A.C. and M. Hasan, 2007. Supercritical carbon dioxide extraction of andrographolide from Andrographis paniculata: Effect of the solvent flow rate, pressure and temperature. Chin. J. Chem. Eng.,15: 877-883.
24. Lee, Y.C., H.H. Lin, C.H. Hsu, C.J. Wang, T.A. Chiang and J.H. Chen, 2010. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur. J. Pharmacol, 632: 23-32.
25. Levita, J., E.P. Istyastono, A. Nawawi, A. Mutholib, LLP. de Esch and S. Ibrahim, 2009a. Analyzing the interaction of andrographolide and neoandrographolide, diterpenoid compounds from Andrographis paniculata (Burm. F)Nees, to COX-2 enzyme by docking simulation. ITB J. Scl, 41A: 110-119.
26. Levita, J., Novriyanti, M., Muchtaridi, M. Moektiwardoyo and E. Halimah, 2009b. Molecular modeling study of andrographolide as an inhibitor of nuclear Facor-kappaB p50 DNA binding. Pekan Ilmiah Universitas Padjadjaran, http://www.lppm.unpad.ac.id/wp-content/uploads/2009/ll/jadwalseminar.pdf
27. Levita, J., A. Nawawi, A. Mutholib and S. Ibrahim, 2010. Andrographolide inhibits COX-2 expression in human fibroblast cells due to its interaction with arginine and histidine in cyclooxygenase site. J. Applied Sci., 10: 1481-1484.
28. Li, J., L. Luo, X. Wang, B. Liao and G. Li, 2009. Inhibition of NF-kappaB expression and allergen-induced airway inflammation in a mouse allergic asthma modelby andrographolide. Cell. Mol. Immunol., 6: 381-385.
29. Lin, F.L., S.J. Wu, S.C. Lee and L.T. Ng, 2009. Antioxidant, antioedema and analgesic activities of andrographis paniculata extracts and their active constituent andrographolide. Phytother. Res., 23: 958-964.
30. Nanduri, S., V.K. Nyavanandi, S.S.R. Thunuguntla, S. Kasu and M.K. Pallerla et al, 2004. Synthesis and structure-activity relationship of andrographolide analogues as cytotoxic agents. Bioorg. Med. Chem. Lett., 14: 4711-4717.
31. Pande, V. and M.J. Ramos, 2005. Molecular recognition of 15-deoxy-D12,14-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. Bioorganic Med. Chem. Lett, 15: 4057-4063.
32. Pande, V., R.K. Sharma, I. Jun-Ichiro, M. Otsuka and M.J. Ramos, 2003. A molecular modeling study of inhibitors of nuclear factor-kappa B (p50)-DNA binding. J. Comput. Aided Mol. Design, 17: 825-836.
33. Rajagopal, S., R.A. Kumar, D.S. Deevi, C. Satyanarayana and R. Rajagopalan, 2003. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Exp. Ther. Oncol., 3: 147-158.
34. Satyanarayana, C, D.S. Deevi, R Rajagopalan, N. Srinivas and S. Rajagopal, 2004. DRF 3188 a novel semi-synthetic analog of andrographolide: Cellular response to MCF7 breast cancer cells. BMC Cancer, 4: 1-8.
35. Sheeja, K., P.K. Shihab and G. Kuttan, 2006. Antioxidant and anti-inflammatory activities of the plant andrographis paniculata nees. Immunopharmacol. Immunotoxicol, 28: 129-140.
36. Shen K.K., T.Y. Liu, C. Xu, L.L. Ji and Z.T. Wang, 2009. Andrographolide inhibits hepatoma cells growth and affects the expression of cell cycle related proteins. Yao Xue Xue Bao, 44: 973-979.
37. Shen, Y.C., C.F. Chen and W.F. Chiou, 2002. Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanisms involved in its anti-inflammatory effect. Br.J. Pharmacol., 135: 399-406.
38. Smith, A.B., B.H. Toder, P.J. Carroll and J. Donohue, 1982. Andrographolide: An x-ray crystallographic analysis. J. Chem. Crystallography, 12: 309-319.
39. Straus, D.S., G. Pascual, M. Li, J.S. Welch and M. Ricotexet-al., 2000. 15-Deoxy-Dl 2,14- prostaglandin J2 inhibits multiple steps in the NF-kB signaling pathway. Proc. Nat. Acad. Sci. USA., 97: 4844-4844.
40. Suebsasana S., P. Pongnaratorn, J. Sattayasai, T. Arkaravichien, S. Tiamkao and C. Aromdee, 2009. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch. Pharm. Res., 32: 1191-1200.
41. Tan, Y., K.H. Chiow, D. Huang and S.H. Wong, 2010. Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells. Br. J. Pharmacol., 159: 1497-1510.
42. Varma, A., H. Padh and N. Shrivastava, 2009. Andrographolide: A new plant-derived antineoplastic entity on horizon. eCAM Adv. Access, 10.1093/ecam/nepl35
43. Visen, P.K.S., B. Shukla, G.K. Patnaik and B.N. Dhawan, 1993. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J. Ethnopharmacol, 40: 131-136.
44. Wang, T., B. Liu, W. Zhang, B. Wilson and J.S. Hong, 2004. Andrographolide reduces inflammationmediated dopaminergic neurodegeneration in mesenphalic neuronglia cultures by inhibiting microglial activation. J. Pharmacol. Exp. Therapeutics, 308: 975-983.
45. Wang, W., J. Wang, S.F. Dong, C.H. Liu and P. Italianix et-al., 2010. Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response. Acta Pharmacol. Sin., 31: 191-201.
46. Xia, Y.F., B.Q. Ye, Y.D. Li, J.G. Wang and X.J. He et al, 2004. Andrographolide attenuates inflammation by inhibition of NF-kB activation through covalent modification of reduced cysteine62 of p50. J. Immunol, 173: 4207-4217.
47. Xu, Y., R.L. Marshall and T.K.S. Mukkur, 2006. Aninvestigation on the antimicrobial activity of Andrographis paniculata extracts and andrographolide in vitro. Asian J. Plant Sci., 5: 527-530.
48. Yamamoto, Y. and R.B. Gaynor, 2001. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest, 107: 135-142.
49. Zhang, Z., J. Jiang, P. Yu, X. Zeng, J.W. Larrick and Y. Wang, 2009. Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment. J. Trans. Med., 7: 62-62.
50. Zhou, J., C.N. Ong, G.M. Hur and H.M. Shen, 2010. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. Biochem. Pharmacol., 79: 1242-1250